GlassScriptPhysician profile
Dean M Brewer
NPI 1821253857
$5,634.45
in general payments reported to CMS, 2019-2025
38 companies · $956 in 2025
The $956 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $638 · 2021: $1,610 · 2022: $1,823 · 2023: $607 · 2025: $956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,563.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $860.17 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $654.95 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $626.10 | 2020-2025 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $503.44 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $252.51 | 2021-2025 | Vraylar |
| Janssen Pharmaceuticals, INC | $251.98 | 2020-2023 | Xarelto |
| Pfizer INC. | $229.54 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $217.94 | 2020-2022 | |
| Amgen INC. | $201.21 | 2020-2025 | Repatha, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.84 | 2020-2023 | Jardiance |
| Dentsply Sirona INC | $151.38 | 2023 | Implant Dentistry |
| Gilead Sciences, INC. | $143.01 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $134.54 | 2022 | |
| Merck Sharp & Dohme LLC | $128.89 | 2020-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Biohaven Pharmaceuticals, INC. | $118.15 | 2020-2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Brewer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.